Improving Pain Management and Decreasing LOS After Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA)

Pain Clinical Trial

Official title: Improving Pain Management and Decreasing Length of Stay After THA and TKA: A Randomized, Patient-Blinded Comparison of Standard of Care Pain Management With and Without Sufentanil

Status Recruiting

Clinical Trial Summary

This two arm, patient blinded, randomized, post market clinical trial in a single orthopedic hospital will determine whether there is improved pain management and decreased length of stay when comparing standard of care pain management with and without sufentanil.

Clinical Trial Description

This two arm, patient blinded, randomized, post market clinical trial in a single orthopedic hospital will determine whether there is improved pain management and decreased length of stay (LOS) when comparing standard of care pain management with and without sufentanil. The objective is to compare LOS between patients who have had primary THA or TKA and have received standard of care peri-operative pain management and one dose of sufentanil 30 mcg sublingual pre-operatively in the operating room and one dose post-operatively in the post anesthesia care unit (PACU) versus those who have received only standard of care peri-operative pain management in a orthopedic specialty hospital. ;

Related Conditions & MeSH terms

• Pain

• NCT number: NCT05307341
• Study type: Interventional
• Source: More Foundation
• Contact: Marc Jacofsky, PhD
• Phone: 623.537.5642
• Email: marc.jacofsky@more-foundation.org
• Status: Recruiting
• Phase: Phase 4
• Start date: March 2022
• Completion date: June 2023